Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Constantin Bode"'
Evaluating Sphingosine and its Analogues as Potential Alternatives for Aggressive Lymphoma Treatment
Publikováno v:
Cellular Physiology and Biochemistry, Vol 34, Iss 5, Pp 1686-1700 (2014)
Background: Ceramide (Cer) and sphingosine (Sph) interfere with critical cellular functions relevant for cancer progression and cell survival. While Cer has already been investigated as a potential drug target for lymphoma treatment, information abou
Externí odkaz:
https://doaj.org/article/b541d67234d14d0bad2d9b81d1b25201
Evaluating Sphingosine and its Analogues as Potential Alternatives for Aggressive Lymphoma Treatment
Publikováno v:
Cellular Physiology and Biochemistry, Vol 34, Iss 5, Pp 1686-1700 (2014)
Background: Ceramide (Cer) and sphingosine (Sph) interfere with critical cellular functions relevant for cancer progression and cell survival. While Cer has already been investigated as a potential drug target for lymphoma treatment, information abou
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 328:963-969
The immunomodulator fingolimod (FTY720) induces lymphopenia by inhibiting lymphocyte egress from thymus and secondary lymphoid organs (SLOs). It is phosphorylated mainly by sphingosine kinase (SK) 2 in vivo. FTY720-phosphate (FTY-P) activated and rap
Autor:
Constantin, Bode, Markus H, Gräler
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 874
Liquid chromatography coupled to tandem mass spectrometry has evolved as the method of choice for the detection of sphingolipid metabolites due to its high sensitivity and superior specificity compared to other methodological approaches. Here, we des
Autor:
Constantin Bode, Markus H. Gräler
Publikováno v:
Methods in Molecular Biology ISBN: 9781617797996
Liquid chromatography coupled to tandem mass spectrometry has evolved as the method of choice for the detection of sphingolipid metabolites due to its high sensitivity and superior specificity compared to other methodological approaches. Here, we des
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::638b2f36bbf2af411eef4e801eacc32e
https://doi.org/10.1007/978-1-61779-800-9_3
https://doi.org/10.1007/978-1-61779-800-9_3
Autor:
Constantin Bode, Markus H. Gräler
Publikováno v:
Archivum immunologiae et therapiae experimentalis. 60(1)
It is well established that the lysophospholipid and signalling molecule sphingosine 1-phosphate (S1P) has many important functions in immune surveillance. S1P is produced from sphingosine by two distinct sphingosine kinases, SphK1 and SphK2, and act
Autor:
Bodo Levkau, Susann Lucke, Karin von Wnuck Lipinski, Markus H. Gräler, Gerd Heusch, Constantin Bode, Petra Keul
Rationale: The role of sphingosine-1-phosphate (S1P) and its receptors in the pathogenesis of atherosclerosis has not been investigated. Objective: We hypothesized that the S1P receptor 3 (S1P 3 ) plays a causal role in the pathogenesis of atheroscle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c18233aeae1cce1e698cc1639ad80e21
https://www.ncbi.nlm.nih.gov/pubmed/21164103
https://www.ncbi.nlm.nih.gov/pubmed/21164103
Autor:
Thomas Budde, Bodo Levkau, Katherine Sattler, Miriam Elter-Schulz, Constantin Bode, Raimund Erbel, Şehriban Elbasan, Markus H. Gräler, Petra Keul, Gerd Heusch, Martina Bröcker-Preuss
Publikováno v:
Basic research in cardiology. 105(6)
High-density lipoproteins (HDL) are the major plasma carriers for sphingosine 1-phosphate (S1P) in healthy individuals, but their S1P content is unknown for patients with coronary artery disease (CAD). The aim of the study was to determine whether th
Autor:
Manju Nagarajan, Markus H. Gräler, Sven-Christian Sensken, Ulrike Peest, Constantin Bode, Oliver Pabst
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 184(8)
Sphingosine kinases (SKs) 1 and 2 produce high concentrations of sphingosine 1-phosphate (S1P) in blood and lymph. In contrast, S1P concentrations in lymphoid tissues are kept low by the S1P-degrading activity of the S1P-lyase. These differences in S
Autor:
S. Elbasan, Martina Bröcker-Preuss, Constantin Bode, Katherine Sattler, Miriam Elter-Schulz, Raimund Erbel, Petra Keul, Gerd Heusch, Markus H. Gräler, Thomas Budde, Bodo Levkau
Publikováno v:
Atherosclerosis Supplements. 11:216